Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Tax Provisions: 2017-2024

  • vTv Therapeutics' Tax Provisions was N/A to $100,000 in Q1 2024 from the same period last year, while for Mar 2024 it was $415,000, marking a year-over-year change of. This contributed to the annual value of $100,000 for FY2024, which is N/A change from last year.
  • Latest data reveals that vTv Therapeutics reported Tax Provisions of $100,000 as of Q1 2024, which was down 50.00% from $200,000 recorded in Q1 2022.
  • vTv Therapeutics' 5-year Tax Provisions high stood at $200,000 for Q1 2022, and its period low was $15,000 during Q1 2021.
  • In the last 2 years, vTv Therapeutics' Tax Provisions had a median value of $150,000 in 2022 and averaged $150,000.
  • Data for vTv Therapeutics' Tax Provisions shows a peak YoY spiked of 1,233.33% (in 2022) over the last 5 years.
  • Over the past 3 years, vTv Therapeutics' Tax Provisions (Quarterly) stood at $100,000 in 2021, then skyrocketed by 1,233.33% to $200,000 in 2022, then reached $100,000 in 2024.
  • Its Tax Provisions was $100,000 in Q1 2024, compared to $200,000 in Q1 2022 and $100,000 in Q3 2021.